\
&
Contact us
\
&
Contact us
Published on | 4 years ago
ProgrammesDue to a technical issue, the check for existence of a GEP has been activated for all projects entering grant preparation in 2022 The issue is now corrected. In case your beneficiaries (from 2021 calls) still see the error message ‘ gender plan missing’, they should re-apply the ‘validate’ button. In the unlikely event that the issue persists, they should contact the service desk.
i) Issue concerning the Gender Equality Plan (GEP)
There was a mistake in the IT implementation of the eligibility criterion on gender equality plans (GEPs). They become obligatory only for calls with deadline after 1.1.2022.
Due to a technical issue, the check for existence of a GEP has been activated for all projects entering grant preparation in 2022 The issue is now corrected. In case your beneficiaries (from 2021 calls) still see the error message ‘ gender plan missing’, they should re-apply the ‘validate’ button. In the unlikely event that the issue persists, they should contact the service desk.
ii) Organisation category ‘International European Research Organization (IERO)
The IERO status applies only to a very limited number of organisations (example: CERN). Due to a change of legal definitions in the transition from H2020 to Horizon Europe, this status became ‘undefined’ for all organisations. This lead to a blocking in the grant agreement preparation.
Applicable solution:
A patch was applied on 20 January, setting the IERO status to ‘ No’ for the vast majority of organisations, thus unblocking the grant agreement preparation. For cases that cannot be corrected automatically, the Legal Entity Appointed Representative (LEAR) of the organisation (or one of the Account Administrators) has to modify the ‘International Organisation’ and ‘IERO’ attributes in the participant management module under the Funding & Tenders Portal.:
Go to My Organisation -> legal information-> edit organisation, and set the fields for 'International Organisation' and 'International European Research Organisation' to the value ('yes' or 'no') applicable to your organisation.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
AI Continent Deployment: Best use of technologies
The LDT4SSC (Local Digital Twins for Smart and Sustainable Communities) project has opened a new cascade funding call to local network of cities, regions, and digital innovators. This call supports co-funding for three Work Strands with a minimum available budget of 10.8 Million euros: - Work strand 1 - interconnecting existing LDTs: At least... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
